Elevance Health: It Has Been Painful, But This Too Shall Pass [Seeking Alpha]
Elevance Health, Inc. (ELV)
Company Research
Source: Seeking Alpha
Elevance's individual exchange business flipped from nicely profitable to decidedly unprofitable, as double-digit increases in medical cost trend met with unanticipated risk-pool changes. In response, the industry increased premiums by 20-30% across individual exchange policies, which should lift Elevance's individual exchange margins into positive territory in 2026. At the current price, Elevance's shares trade at a single-digit multiple of our estimate of normalized forward earnings power per share. We deem this attractive, and in fact added modestly to our position in 2025. jetcityimage/iStock Editorial via Getty Images The following segment was excerpted from the Sequoia Fund ( SEQUX ) Q4 2025 Shareholder Letter. Shares of Elevance Health, Inc. ("Elevance") returned -3% in 2025. In short, 2025 was another busy and difficult year for US health insurers, Elevance included. Though we expect the This article was written by Quick Insights Persistent medical cost pres
Show less
Read more
Impact Snapshot
Event Time:
ELV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ELV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ELV alerts
High impacting Elevance Health, Inc. news events
Weekly update
A roundup of the hottest topics
ELV
News
- Elevance Health (NYSE:ELV) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating. They now have a $358.00 price target on the stock.MarketBeat
- Elevance Health (NYSE:ELV) had its price target raised by analysts at JPMorgan Chase & Co. from $394.00 to $397.00. They now have an "overweight" rating on the stock.MarketBeat
- Elevance Health (NYSE:ELV) had its price target lowered by analysts at Truist Financial Corporation from $400.00 to $390.00. They now have a "buy" rating on the stock.MarketBeat
- Elevance Health (NYSE:ELV) had its price target lowered by analysts at Jefferies Financial Group Inc. from $401.00 to $395.00. They now have a "buy" rating on the stock.MarketBeat
- Elevance Health (NYSE:ELV) had its price target lowered by analysts at Sanford C. Bernstein from $431.00 to $409.00. They now have an "outperform" rating on the stock.MarketBeat
ELV
Earnings
- 1/28/26 - Beat
ELV
Sec Filings
- 1/28/26 - Form 8-K
- 1/14/26 - Form 3
- 12/10/25 - Form 8-K
- ELV's page on the SEC website